SHERRY WASHBURN: Open Payments
NPI 1154671527 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,714 in 112 payments from 23 companies in 2025. Trend: 2023 $1,266 · 2024 $1,942 · 2025 $1,714
Food & beverage: $1,714
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $198 |
| Otsuka America Pharmaceutical, Inc. | 13 | $170 |
| Supernus Pharmaceuticals, Inc. | 22 | $160 |
| Novo Nordisk Inc | 6 | $118 |
| GlaxoSmithKline, LLC. | 6 | $114 |
| Lilly USA, LLC | 6 | $110 |
| Lundbeck LLC | 4 | $98 |
| PFIZER INC. | 4 | $88 |
| Indivior Inc. | 4 | $66 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
Products named: REXULTI, Qelbree, TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, NURTEC ODT, Ozempic, SUBLOCADE.
Industry payments across MI — which companies pay providers there.
